Glenmark launches Covid-19 Drug
Glenmark Pharmaceuticals on Saturday launched an antiviral drug Favipiravir (brand name FabiFlu®) for the treatment of mild to moderate covid-19 patients.
Favipiravir has shown clinical evidence showing encouraging results in patients…